A5010506546- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Cardiac Arrest and Resuscitation
- Cardiac Valve Diseases and Treatments
- Congenital Heart Disease Studies
- Cardiac pacing and defibrillation studies
- Aortic Disease and Treatment Approaches
- Energy Harvesting in Wireless Networks
- Wireless Power Transfer Systems
- Heart Failure Treatment and Management
- Cardiac and Coronary Surgery Techniques
- Transplantation: Methods and Outcomes
- Wireless Body Area Networks
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Function and Risk Factors
- Long-Term Effects of COVID-19
- Infective Endocarditis Diagnosis and Management
- Aortic aneurysm repair treatments
- Pericarditis and Cardiac Tamponade
- Fuel Cells and Related Materials
- Atrial Fibrillation Management and Outcomes
- Advanced Battery Technologies Research
- Intensive Care Unit Cognitive Disorders
- Takotsubo Cardiomyopathy and Associated Phenomena
- Adrenal and Paraganglionic Tumors
IRCCS San Camillo Hospital
2013-2024
Carlo Forlanini Hospital
2010-2024
Ospedale Sant'Anna
2023-2024
Ospedale generale di zona San Camillo Treviso
2022-2024
Azienda Ospedaliera San Camillo-Forlanini
2018-2022
San Diego Cardiac Center
2021
Nini Hospital
2020-2021
Two centrifugal pumps, the RotaFlow (Maquet, Jostra Medizintechnik AG, Hirrlingen, Germany) and Levitronix CentriMag (Levitronix LCC, Waltham, MA, USA), used in central or peripheral veno-arterial extracorporeal membrane oxygenation (ECMO) support systems have been investigated, terms of double-center experience, as treatment for patients with refractory cardiogenic shock (CS). Between January 2006 December 2012, 228 consecutive adult were supported on (n=213) (n=15) ECMO, at our...
An increased need of extracorporeal membrane oxygenation (ECMO) support is going to become evident as treatment SARS-CoV-2 respiratory distress syndrome. This the first report Italian Society for Cardiac Surgery (SICCH) on preliminary experience with COVID-19 patients receiving ECMO support. Data from 12 hospitals participating in SICCH were retrospectively analyzed. Between March 1 and September 15, 2020, a veno-venous (VV) system was installed 67 (94%) veno-arterio-venous four (6%). Five...
It has been well assessed that women have widely under-represented in cardiovascular clinical trials. Moreover, a significant discrepancy pharmacological and interventional strategies reported. Therefore, poor outcomes more mortality shown many diseases. Pharmacokinetic pharmacodynamic differences drug metabolism also described so effectiveness could be different according to sex. However, awareness about the gender gap remains too scarce. Consequently, gender-specific guidelines are...
Abstract Early planned institution of temporary right ventricular assist device ( RVAD ) support with the C entri M ag L evitronix LLC , W altham, MA USA in left LVAD recipients was compared permanent biventricular BVAD or total artificial heart TAH support. Between 2007 and 2011, 77 patients (age range: 25–70 years) preoperative evidence dysfunction U niversity P ennsylvania score >50; ichigan >5) were included. Forty‐six (38 men; median age 54.5 years, underwent placement combined...
Abstract The novel Permanent Life Support (PLS; Maquet, Jostra Medizintechnik AG, Hirrlingen, Germany) as peripheral veno‐arterial extracorporeal membrane oxygenation (ECMO) support system has been investigated treatment for patients with refractory cardiogenic shock (CS). Between January 2007 and July 2011, 73 consecutive adult were supported on PLS ECMO at our institution (55 men; age 60.3 ± 11.6 years, range: 23–84 years). Indications failure to wean from cardiopulmonary bypass in the...
This study deals with the development of a new power supply system implanted in human body to feed several implantable medical devices (IMDs). The is energized from outside via transcutaneous wireless transfer (WPT) link subcutaneous pocket. internal equipped backup battery and can continuously multiple IMDs for maximum 25 W. As demonstration proposed solution, different are considered. An experimental setup was carried out laboratory tests were performed on real demonstrate feasibility...
Hypertrophic cardiomyopathy (HCM) is a non-rare genetic cardiomyopathy, with an estimated prevalence of 1:500, characterized by increase in the left ventricular wall thickness absence increased loading conditions. The hypertrophy mostly asymmetric and predominantly affects basal septum anterior wall. Left outflow tract obstruction, at rest or after provocative tests, detected many patients represents primary cause reduced functional capacity, as well independent predictor sudden cardiac...
An approach is reported for right ventricle temporary mechanical support in long-term axial left ventricular assist device (LVAD) patients preoperatively judged at high risk of (RV) failure. The timing RV (RVAD) weaning and the technique its removal through a mini-thoracotomy are described. This strategy provides good outcome LVAD recipients avoiding immediate postoperative
The Levitronix CentriMag (Levitronix LLC, Waltham, MA) ventricular assist device (VAD) is a magnetically levitated rotary pump designed for temporary extracorporeal support. Between February 2004 and May 2010, 42 consecutive adult patients were supported with at our institution (32 men; age 62.3 ± 10.5 years, range: 31-76 years). Indications support (group A, n = 37) failure to wean from the cardiopulmonary bypass in setting of postcardiotomy (n 23), primary donor graft 4), or right after...
Objectives: The Harlequin syndrome is a complication observed in patients receiving peripheral venoarterial extracorporeal membrane oxygenation. This condition defined as critical variation the oxygen saturation between upper and lower part of body deriving from poor lung function. Methods: Between July 2018 November 2019, total 60 (42 men 18 women; mean age 57.4 ± 10.0 years; range = 28-71 years) underwent oxygenation our center. was identified eight cases (six two 13.3%)...
This article deals with the electromagnetic interference (EMI) in a cardiac implantable electronic device (e.g., cardioverter-defibrillator or resynchronization therapy) generated by left ventricular assisted (LVAD) powered wireless power transfer (WPT) system. Wireless LVAD, not yet available market, is currently being investigated for many aspects spanning from electronics, hydraulic, electrical feeding, mechanical, and its possible impact on other implanted devices, such as (CIED). No...
The excellent results with left ventricular assist devices (LVADs) have revolutionized the treatment options for end-stage heart failure. use of pulsatile is associated significant comorbidity and limited durability. axial-flow HeartMate II LVAD represents new generation devices. clinical this pump resulted in superior outcomes. We review technology, management, usage our experience.Between 3/2002 12/2008, 18 transplantable adult patients were supported on long-term at institution (13 men,...
Right ventricular failure after continuous-flow left assist device (LVAD) implantation is still an unsolved issue and remains a life-threatening event for patients. We undertook this study to determine predictors of the patients who are candidates isolated LVAD therapy as opposed biventricular support (BVAD). reviewed demographic, echocardiographic, hemodynamic, laboratory variables 258 underwent both unplanned BVAD because early right insertion, between 2006 2017 (LVAD = 170 88). The final...
: Video-assisted minimally invasive mitral valve surgery can be performed through different approaches. The aim of the study was to report our early results and compare external transthoracic aortic clamping with endoaortic balloon occlusion techniques according experience.: Between January 2000 March 2010, 138 patients (103 women, aged 58.4 ± 10.2 years) underwent video-assisted a right thoracotomy. Cardiopulmonary bypass instituted by femoral arterial bicaval cannulation active venous...
: Video-assisted minimally invasive mitral valve surgery can be performed through different approaches. The aim of the study was to report our early results and compare external transthoracic aortic clamping with endoaortic balloon occlusion techniques according experience.: Between January 2000 March 2010, 138 patients (103 women, aged 58.4 ± 10.2 years) underwent video-assisted a right thoracotomy. Cardiopulmonary bypass instituted by femoral arterial bicaval cannulation active venous...
Abstract Reduced order modeling (ROM) techniques are numerical methods that approximate the solution of parametric partial differential equation (PED) by properly combining high-fidelity solutions problem obtained for several configurations, i.e. chosen values physical/geometrical parameters characterizing problem. By starting from a database related to certain parameters, we apply proper orthogonal decomposition with interpolation (PODI) and then reconstruct variables interest new different...
This article deals with the design of a wireless powering system for left ventricular assist device (LVAD). The modern LVAD is mainly miniaturized blood pump attached to heart and driven by an electric motor powered cable driveline that exits patient's body through skin be connected external battery. portal exterior environment this can cause frequent severe infections. goal elimination link between interior human body. To aim, innovative proposed adopting power transfer (WPT) technology...
Background Right ventricular failure (RVF) is a severe event that increases perioperative mortality after left ventricle assist device (LVAD) implantation. (RV) function particularly affected by the LVAD speed altering RV preload and afterload as well position of interventricular septum. However, there are no studies focusing on relationship between pump optimization risk factors for development late RVF. Methods Between 2015 2019, 50 patients received implantation at San Camillo Hospital in...
Introduction The treatment of patients with cardiogenic shock (CS) encompasses several health technologies including Impella pumps and venoarterial extracorporeal membrane oxygenation (VA-ECMO). However, while they are widely used in clinical practice, information on resource use quality life (QoL) associated these devices is scarce. aim this study is, therefore, to collect comparatively assess socioeconomic data versus VA-ECMO for the severe CS, ultimately conduct both a cost-effectiveness...